Cargando…
Adenosine receptors as emerging therapeutic targets for diabetic kidney disease
Diabetic kidney disease (DKD) is now a pandemic worldwide, and novel therapeutic options are urgently required. Adenosine, an adenosine triphosphate metabolite, plays a role in kidney homeostasis through interacting with four types of adenosine receptors (ARs): A(1)AR, A(2A)AR, A(2B)AR, and A(3)AR....
Autores principales: | Pak, Eun Seon, Cha, Jin Joo, Cha, Dae Ryong, Kanasaki, Keizo, Ha, Hunjoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Nephrology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590297/ https://www.ncbi.nlm.nih.gov/pubmed/36239063 http://dx.doi.org/10.23876/j.krcp.22.011 |
Ejemplares similares
-
Orally active, species-independent novel A(3) adenosine receptor antagonist protects against kidney injury in db/db mice
por: Dorotea, Debra, et al.
Publicado: (2018) -
Fyn Kinase: A Potential Therapeutic Target in Acute Kidney Injury
por: Uddin, Md Jamal, et al.
Publicado: (2020) -
Dual Actions of A(2A) and A(3) Adenosine Receptor Ligand Prevents Obstruction-Induced Kidney Fibrosis in Mice
por: Pak, Eun Seon, et al.
Publicado: (2021) -
Inhibition of Src Family Kinases Ameliorates LPS-Induced Acute Kidney Injury and Mitochondrial Dysfunction in Mice
por: Pak, Eun Seon, et al.
Publicado: (2020) -
Diabetic kidney disease, revisited: where do we stand?
por: Cha, Dae Ryong
Publicado: (2022)